5-Aminolevulinic acid-derived tumor fluorescence: The diagnostic accuracy of visible fluorescence qualities as corroborated by spectrometry and histology and postoperative imaging

Neurosurgery

Volumn 74, Issue 3, 2014, Pages 310-319

  Stummer, Walter ^a   Tonn, Jörg Christian ^b   Goetz, Claudia ^c   Ullrich, Winfried ^d   Stepp, Herbert ^b   Bink, Andrea ^a   Pietsch, Thorsten ^e   Pichlmeier, Uwe ^f  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Asklepios Klinik Nord Heidberg   (Germany)

^d Department of Neurosurgery   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f MEDAC GMBH   (Germany)

Author keywords

5 Aminolevulinic acid; Fluorescence guided resection; Malignant glioma; Sensitivity; Specificity; Spectrometry

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CRANIOTOMY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FLUORESCENCE; GLIOBLASTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROIMAGING; NEURONAVIGATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE IMAGING; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SPECTROMETER; SPECTROMETRY; SURGICAL MICROSCOPE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AMINOLEVULINIC ACID; BIOMETRY; BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; SPECTRUM ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896701400     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000267     Document Type: Article

References (33)

1. Dez Valle R, Tejada Solis S, Idoate Gastearena MA, Garca de Eulate R, Domnguez Echvarri P, AristuMendiroz J. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in singlecenter experience. J Neurooncol. 2011;102(1):105-113.
2. Floeth FW, Stummer W. The value of metabolic imaging in diagnosis and resection of cerebral gliomas. Nat ClinPract Neurol. 2005;1(2):62-63.
3. Nabavi A, Thurm H, Zountsas B, et al. Five-aminolevulinic acid for fluorescenceguided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery. 2009;65:1070-1077.
4. Aldave G, Tejada S, Pay E, et al. Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery. Neurosurgery. 2013;72:915-920.
5. Pichlmeier U, Bink A, Schackert G, Stummer W. Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol. 2008;10(6):1025-1034.
6. Roberts DW, Valdes PA, Harris BT, et al. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between d- aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article. J Neurosurg. 2011;114(3):595-603.
7. Roessler K, Becherer A, Donat M, Cejna M, Zachenhofer I. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery. Neurol Res. 2012;34(3):314-317.
8. Schucht P, Beck J, Abu-Isa J, et al. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brainmapping. Neurosurgery. 2012;71(5): 927-935.
9. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescenceguided resection of glioblastoma multiforme by using 5-aminolevulinic acidinduced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000;93(6):1003-1013.
10. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ.Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006; 7 (5):392-401.
11. Stummer W, Stocker S, Wagner S, et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery. 1998;42(3):518-525.
12. Valds PA, Fan X, Ji S, Harris BT, Paulsen KD, Roberts DW. Estimation of brain deformation for volumetric image updating in protoporphyrin IX fluorescenceguided resection. Stereotact Funct Neurosurg. 2010;88(1):1-10.
13. Valds PA, Leblond F, Kim A, et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg. 2011;115(3):11-17.
14. Piccirillo SG, Dietz S, Madhu B, et al. Fluorescence-guided surgical sampling of glioblastoma identifies phenotypically distinct tumour-initiating cell populations in the tumour mass and margin. Br J Cancer. 2012;107(3):462-468.
15. Stummer W, Stepp H, Mller G, Ehrhardt A, Leonhard M, Reulen HJ. Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien). 1998;140(10):995-1000.
16. Widhalm G,Wolfsberger S, Minchev G, et al. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer. 2010;116(6):1545-1552.
17. Hefti M, von Campe G, Moschopulos M, Siegner A, Looser H, Landolt H.5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion. Swiss Med Wkly. 2008;138(11-12):180-185.
18. Idoate MA, Dez Valle R, Echeveste J, Tejada S. Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulininic acidinduced fluorescence. Neuropathology. 2011;31(6):575-582.
19. Shapiro DE. The interpretation of diagnostic tests. Stat Methods Med Res. 1999; 8 (2):113-134.
20. Ando T, Kobayashi E, Liao H, et al. Precise comparison of protoporphyrin IX fluorescence spectra with pathological results for brain tumor tissue identification. Brain Tumor Pathol. 2011;28(1):43-51.
21. Utsuki S, Oka H, Sato S, et al. Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol Med Chir (Tokyo). 2007;47(5):210-214.
22. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastomamultiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190-198.
23. McGirt MJ, Chaichana KL, Attenello FJ, et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery. 2008;63(4):700-707.
24. Stummer W, Reulen HJ, Meinel T, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008;62(3):564-576.
25. Stummer W, van den Bent MJ, Westphal M. Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion. Acta Neurochir (Wien). 2011;153(6):1211-1218.
26. Kim A, Khurana M, Moriyama Y, Wilson BC. Quantification of in vivo fluorescence decoupled from the effects of tissue optical properties using fiber-optic spectroscopy measurements. J Biomed Opt. 2010;15(6):067006.
27. Ramanujam N. Fluorescence spectroscopy of neoplastic and non-neoplastic tissues. Neoplasia. 2000;2(1-2):89-117.
28. Richards-Kortum R, Sevick-Muraca E. Quantitative optical spectroscopy for tissue diagnosis. Annu Rev Phys Chem. 1996;47:555-606.
29. Sokolov K, Follen M, Richards-Kortum R. Optical spectroscopy for detection of neoplasia. Curr Opin Chem Biol. 2002;6(5):651-658.
30. Haj-Hosseini N, Richter J, Andersson-Engels S, Wrdell K. Optical touch pointer for fluorescence guided glioblastoma resection using 5-aminolevulinic acid. Lasers Surg Med. 2010;42(1):9-14.
31. Ishihara R, Katayama Y, Watanabe T, Yoshino A, Fukushima T, Sakatani K. Quantitative spectroscopic analysis of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence intensity in diffusely infiltrating astrocytomas. Neurol Med Chir (Tokyo). 2007;47(2):53-57.
32. Utsuki S, Oka H,Miyajima Y, Shimizu S, Suzuki S, Fujii K. Auditory alert system for fluorescence-guided resection of gliomas. Neurol Med Chir (Tokyo). 2008;48 (2):95-98.
33. Utsuki S, Oka H, Sato S, et al. Possibility of using laser spectroscopy for the intraoperative detection of nonfluorescing brain tumors and the boundaries of brain tumor infiltrates. Technical note. J Neurosurg. 2006;104(4):618-620.